Would you like to receive important updates about Mallinckrodt PLC like earnings dates and more?
The Year To Date (YTD) return is -28.57%.
The 52 Week Low stock price is 15.27 set on Fri, Feb 9, 2018 which is 11 days ago.
The current price per share is 10.02% above the 52 week low.
The 52 Week High stock price is $55.32 set on Wed, Feb 22, 2017 which is 363 days ago.
The current price per share is -69.63% below the 52 week high.
The All Time High stock price is $134.26 set on Mon, Mar 23, 2015 which is 1,065 days ago.
The current price per share is -87.49% below the all time high.
The Mallinckrodt 5 year stock chart shows the historical prices over the previous 60 months.
The Mallinckrodt 1 year stock chart shows the historical prices over the previous 12 months.
The 50 Day Moving Average is at $42.58 which is 60.54% above the stock price of $16.80.
The 200 Day Moving Average is at 47.40 which is 64.56% above the stock price of $16.80.
Because both the 50 DMA and 200 DMA are above the current stock price, this can be considered a bearish technical indicator.
Since the stock price is very far from both moving averages, a price retracement towards the moving averages should not be unexpected.
Mallinckrodt PLC is a Health Care stock that trades on the NYSE and has a market capitalization of $1.60 Billion.
Mallinckrodt public limited company develops, manufactures, markets and distributes branded and generic specialty pharmaceutical products and therapies. The Company focuses on various therapeutic areas, such as autoimmune and rare disease specialty areas, including neurology, rheumatology, nephrology, ophthalmology and pulmonology; immunotherapy and neonatal critical care respiratory therapies; analgesics and hemostasis products, and central nervous system drugs. Its segments include Specialty Brands and Specialty Generics. The Specialty Brands segment produces and markets branded pharmaceutical products and therapies. The Specialty Generics segment produces and markets specialty generic pharmaceuticals and active pharmaceutical ingredient (API) consisting of biologics, medicinal opioids, synthetic controlled substances, acetaminophen and other active ingredients. Its product portfolio includes Acthar, Inomax, Ofirmev, Therakos immunotherapy, Hemostasis products and StrataGraft.
Below are several other Biotech & Pharma stocks include AbbVie Inc (ABBV), Allergan PLC (AGN), Alexion Pharmaceuticals Inc (ALXN), Amgen Inc (AMGN), Biogen Inc (BIIB), BioMarin Pharmaceutical Inc (BMRN), Bristol-Myers Squibb Co (BMY), Celgene Corp (CELG), Endo International PLC (ENDP), Gilead Sciences Inc (GILD), .
The EPS is -$0.02 and the P/E Ratio is 0.
A negative Earnings Per Share (EPS) means that this company is losing money and not profitable at this time.
Stocks can make big percentage moves on the earnings announcement.
Companies announce earnings either before the market open or after the close.
The Earnings Release Date for Mallinckrodt PLC was Tue, Nov 7, 2017.
Since this earnings release 105 days ago, the stock price is down by -46.12%.
Many investors know the importance of a companies earnings report. Also, the market reaction to the earnings release can be even more important and can help in making a prediction of a future price forecast of the shares.
A significant post earnings announcement percentage move can continue or reverse an existing trend for several days or weeks after the earnings date.
The next Earnings Release Date is, before the market open, on Tue, Feb 27, 2018, which is in 7 days.2018-02-27 06:00:002018-02-27 13:00:00America/New_YorkMallinckrodt PLC (MNK) EarningsVisit http://www.symbolsurfing.com/MNK for more information.United StatesSymbol Surfing[email protected]
MNK currently does not pay a dividend.
You may like this list of best dividend stocks of 2018.